coronavirus vaccine being developed at the University of Oxford is safe and induces an immune reaction, findings of the first phases of the study suggest.
The findings on the Oxford vaccine trial were published in medical journal, The Lancet on Monday.It says: "Our preliminary findings show that the candidate ChAdOx1 nCoV-19 vaccine given as a single dose was safe and tolerated."No serious adverse reactions to ChAdOx1 nCoV-19 occurred.
Read more on manchestereveningnews.co.uk